Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.85 |
| ▸ | MEN1 | O00255 | 1/20 | 0.85 |
| ▸ | LMNA | P02545 | 1/20 | 0.85 |
| ▸ | PKM | P14618 | 1/20 | 0.85 |
| ▸ | APEX1 | P27695 | 1/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.85 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 1/20 | 0.65 |
| ▸ | CA9 | Q16790 | 1/20 | 0.65 |
| ▸ | DEGS1 | O15121 | 3/20 | 0.64 |
| ▸ | SNCA | P37840 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | NQO2 | P16083 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8439715 | 1.00 | POLB (0.85) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL30319980 | 0.92 | POLB (1.00) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL1353478 | 0.92 | POLB (1.00) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL137276 | 0.92 | POLB (1.00) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL2128727 | 0.92 | POLB (1.00) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL9681496 | 0.92 | POLB (1.00) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL8442129 | 0.90 | POLB (0.96) | POLBTDP1MEN1LMNAPKM | |
| Hydrochloric Acid SCHEMBL8640632 | 0.90 | POLB (0.96) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL900928 | 0.90 | DEGS1 (0.75) | POLBTDP1MEN1LMNAPKM | |
| SCHEMBL8420639 | 0.90 | DEGS1 (0.75) | POLBTDP1MEN1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8664341-B2 | Vinylbenzyl ethers of polycyclopentadiene polyphenol | DOW GLOBAL TECHNOLOGIES, LLC (US) | 2014-03-04 | — | — | US | disclosed |
| US-8519066-B2 | Poly(allyl ethers) of polycyclopentadiene polyphenol | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-08-27 | — | — | US | disclosed |
| US-20130211015-A1 | VINYLBENZYL ETHERS OF POLYCYCLOPENTADIENE POLYPHENOL | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-08-15 | — | — | US | disclosed |
| EP-2563756-A1 | POLY(ALLYL ETHER)S OF POLYCYCLOPENTADIENE POLYPHENOL | Dow Global Technologies LLC (US) | 2013-03-06 | — | — | EP | disclosed |
| EP-2563755-A1 | VINYLBENZYL ETHERS OF POLYCYCLOPENTADIENE POLYPHENOL | Dow Global Technologies LLC (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20130041114-A1 | POLY(ALLYL ETHERS) OF POLYCYCLOPENTADIENE POLYPHENOL | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-02-14 | — | — | US | disclosed |
| WO-2011136847-A1 | POLY(ALLYL ETHER)S OF POLYCYCLOPENTADIENE POLYPHENOL | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011136845-A1 | VINYLBENZYL ETHERS OF POLYCYCLOPENTADIENE POLYPHENOL | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-03 | — | — | WO | disclosed |
| US-20090176773-A1 | Non-Peptidic Inhibitors of AKAP/PKA Interaction | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2009-07-09 | — | — | US | disclosed |
| US-20090176773-A1 | Non-Peptidic Inhibitors of AKAP/PKA Interaction | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2009-07-09 | — | — | US | disclosed |
| EP-0409069-B1 | Mesogenic polycyanates and polycyanamides and thermosets thereof | DOW CHEMICAL CO (US) | 1999-06-02 | — | — | EP | disclosed |
| US-5612479-A | Polyphenols containing mesogenic moieties as lateral substituents | THE DOW CHEMICAL COMPANY (US) | 1997-03-18 | — | — | US | disclosed |
| US-5470946-A | Products resulting from polymerizing or curing polycyanates containing mesogenic moieties as lateral substituents | THE DOW CHEMICAL COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| US-5442039-A | Rod-like mesogenic structures incorporated into polytriazine products; improved tensile strength, flexural strength | THE DOW CHEMICAL COMPANY (US) | 1995-08-15 | — | — | US | disclosed |
| US-5428125-A | Liquid crystalline | THE DOW CHEMICAL COMPANY (US) | 1995-06-27 | — | — | US | disclosed |
| US-5206321-A | Polycyanates containing mesogenic moieties as lateral substituents | THE DOW CHEMICAL COMPANY (US) | 1993-04-27 | — | — | US | disclosed |
| EP-0409069-A2 | Mesogenic polycyanates and thermosets thereof | THE DOW CHEMICAL COMPANY (US) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176773-A1 | Non-Peptidic Inhibitors of AKAP/PKA Interaction | PRKCH, AIP, PRKCE | POLB 4651/4885TDP1 3383/4885MEN1 4118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.